Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | SGC0946 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
SGC0946 inhibits DOT1L, resulting in reduced viability of leukemia cells with MLL fusions (PMID: 23250418, PMID: 28209620). |
| DrugClasses | DOT1L Inhibitor 3 |
| CAS Registry Number | 1561178-17-3 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| I-BET151 + SGC0946 | I-BET151 SGC0946 | 1 | 0 |
| SGC0946 | SGC0946 | 0 | 0 |